Cytosorbents Corp
CTSO
75 hedge funds and large institutions have $89.2M invested in Cytosorbents Corp in 2018 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 21 increasing their positions, 5 reducing their positions, and 11 closing their positions.
320% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 5
236% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 11
222% more capital invested
Capital invested by funds: $27.7M → $89.2M (+$61.6M)
200% more call options, than puts
Call options by funds: $1.31M | Put options by funds: $436K
53% more funds holding
Funds holding: 49 → 75 (+26)
12.79% more ownership
Funds ownership: 13.32% → 26.11% (+13%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$14.9M |
| 2 |
State Street
Boston,
Massachusetts
|
+$3.91M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$2.47M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$2.44M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.22M |
| 2 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
-$1.8M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.09M |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$521K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$362K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
76
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1.09M | -115,419 | Closed |
|
|
BCM
77
BlueCrest Capital Management
St Helier,
Jersey
| – | -$521K | -73,907 | Closed |
|
|
TEE
78
Tibra Equities Europe
London,
United Kingdom
| – | -$362K | -51,313 | Closed |
|
|
FAM
79
Fortaleza Asset Management
Chicago,
Illinois
| – | -$265K | -37,615 | Closed |
|
|
ECM
80
Element Capital Management
New York
| – | -$213K | -30,170 | Closed |
|
|
CS
81
Credit Suisse
Zurich,
Switzerland
| – | -$98K | -13,868 | Closed |
|
82
Man Group
London,
United Kingdom
| – | -$97K | -13,760 | Closed |
|
|
VF
83
Virtu Financial
New York
| – | -$97K | -13,733 | Closed |
|
84
Citadel Advisors
Miami,
Florida
| – | -$107K | -11,291 | Closed |
|
|
TRCT
85
Tower Research Capital (TRC)
New York
| – | -$8K | -1,072 | Closed |
|
|
IWM
86
IHT Wealth Management
Chicago,
Illinois
| – | -$1K | -200 | Closed |
|
CTSO Hedge Fund Activity: Q2 2018 in Review
75 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q2 2018, worth a combined $89.2M — up 222% from $27.7M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new CTSO positions and 11 closed out — a net gain of 26 holders — while 21 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock, adding an estimated $14.9M. The largest seller was Millennium Management, cutting an estimated $3.22M.
- 75 institutional investors held Cytosorbents Corp (CTSO) as of Q2 2018, up from 49 in Q1 2018.
- Funds reported $89.2M of Cytosorbents Corp stock for Q2 2018, up 222% quarter-over-quarter.
- 37 funds opened new Cytosorbents Corp positions in Q2 2018 and 11 closed out, a net change of +26 holders.
- The largest Cytosorbents Corp buyer in Q2 2018 was BlackRock, an estimated $14.9M added.
- The largest Cytosorbents Corp seller in Q2 2018 was Millennium Management, an estimated $3.22M sold.
Based on aggregated 13F filings for Q2 2018.